13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000950123-25-002628
Total Value
$74.4M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $56.2M | 75.61% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $12.9M | 17.35% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $5.2M | 7.04% |